Results 141 to 150 of about 52,371 (280)

Clinical Impact of CTLA4 and LAG3 Single‐Nucleotide Polymorphisms in Multiple Myeloma Patients Treated With BCMA CAR T‐Cell Therapy

open access: yesHematological Oncology, Volume 44, Issue 6, November 2026.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy targeting B‐cell maturation antigen (BCMA) is a highly effective treatment option for patients with relapsed refractory multiple myeloma (RRMM). However, reliable biomarkers predicting long‐term treatment response remain elusive. Germline single‐nucleotide polymorphisms (SNPs) in immune checkpoint
Elisa Suter   +7 more
wiley   +1 more source

LOOCV accuracy average across classifiers in the DLBCL dataset.

open access: yes, 2015
LOOCV accuracy average across classifiers in the DLBCL dataset.
Saeid Nahavandi (714568)   +3 more
core   +1 more source

Non‐Relapse Mortality With Bispecific Antibodies in Hematologic Malignancies: A Dual Systematic Review and Pharmacovigilance Analysis

open access: yesHematological Oncology, Volume 44, Issue 6, November 2026.
ABSTRACT Bispecific antibodies (BsAbs) redirect T‐cells to tumor antigens in an MHC‐independent manner. These universally available, off‐the‐shelf products have demonstrated unprecedented efficacy in heavily pretreated patients with relapsed/refractory (R/R) hematological malignancies (HMs).
Sohaib Irfan   +7 more
wiley   +1 more source

Primary Prostatic Diffuse Large B‐Cell Lymphoma Mimicking Prostate Cancer With a Normal Prostate‐Specific Antigen Level

open access: yesIJU Case Reports, Volume 9, Issue 6, November 2026.
ABSTRACT Introduction Primary prostatic lymphoma is rare and may mimic prostate cancer clinically and radiologically. Case Presentation A 66‐year‐old man was referred for evaluation of suspected advanced prostate cancer. Despite a normal prostate‐specific antigen level of 0.573 ng/mL, imaging revealed a prostatic mass with suspected bladder invasion ...
Kota Amamoto   +9 more
wiley   +1 more source

DLBCL

open access: yesOncology Times, 2008
openaire   +3 more sources

Distribution and clinical impact of molecular subtypes with dark zone signature of DLBCL in a Japanese real-world study

open access: yes
The distribution and clinical impact of cell-of-origin (COO) subtypes of diffuse large B-cell lymphoma (DLBCL) outside Western countries remain unknown. Recent literature also suggests that there is an additional COO subtype associated with the germinal ...
Nishikori, Asami   +36 more
core   +1 more source

Mixed Invasive Fungal Pneumonia Caused by Aspergillus, Candida, Mucor in an Immunocompromised Host

open access: yesRespirology Case Reports, Volume 14, Issue 11, November 2026.
We report a case of mixed invasive fungal pneumonia caused by Aspergillus, Candida and Mucor species in an immunocompromised host, highlighting the diagnostic and therapeutic implications of concurrent opportunistic fungal infections. ABSTRACT Invasive fungal pneumonia (IFP) is a life‐threatening complication in immunocompromised patients, particularly
Taeyun Kim   +6 more
wiley   +1 more source

Targeting transcription factors associated with hemoglobinopathies: Lessons from successful interventions and implications for cancer

open access: yesMolecular Oncology, Volume 20, Issue 10, Page 2533-2566, October 2026.
This review summarizes the transcription factors, repressive chromatin‐modifying complexes, and epigenetic mechanisms that control fetal hemoglobin repression. Notably, many regulators of γ‐globin silencing also function in transcriptional and epigenetic networks that drive cancer, highlighting opportunities to translate advances in hemoglobinopathy ...
Meigen Yu   +3 more
wiley   +1 more source

Spatial biology in cancer epigenetics

open access: yesMolecular Oncology, Volume 20, Issue 10, Page 2393-2409, October 2026.
Spatial epigenomics combines molecular profiling with tissue architecture to reveal how gene regulation is organized within intact tissues. In cancer, these technologies uncover the mechanisms driving tumor heterogeneity and microenvironmental interactions, opening new opportunities for biomarker discovery and precision medicine.
Eva Crespo‐García, Manel Esteller
wiley   +1 more source

Home - About - Disclaimer - Privacy